Frontlight ResearchEarly access
CompletedNo phase
Culturally Tailored Cannabis Use Disorder App
Key facts
- Who runs it
- University of Houston
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 14 Jun 2023
- Ended
- 31 Jan 2024
- Type of study
- Interventional
- Treatments tested
- CT-MICART App
- Control
- Record updated
- 7 May 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- at least 18 years of age
- identify as Black/African American
- CUD per CUPIT-R
- willing and able to complete study appointments
- motivated to reduce cannabis (≥5 on a 10-point scale)
- score ≥ 4 on the REALM-SF indicating ≥ 6th grade English literacy level (needed to use app)
- report cannabis use to manage anxiety/stress in the past month
Who cannot take part
- report of current or intended participation in a concurrent substance use treatment, including pharmacotherapy or psychotherapy for CUD not provided by researchers
- legal mandate or substance misuse treatment
- ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or depression
- not being fluent in English
- pregnant of planning to become pregnant within the next six months (assessed via self-report)
Where in United States
- University of HoustonHouston, United States
About the trial
What the trial wants to find out
The present study aims to address disparities in cannabis use outcomes among African American/Black (hereby referred to as Black) adults with cannabis use disorder (CUD). The specific aims of this study are: (1) to develop a culturally adapted, mobile app for Black cannabis users (CT-MICART) using knowledge from the current research team, published literature, expert opinion, and feedback from the Community Research Advisory Board (CRAB), (2) to pilot test CT-MICART and (3) focus on analysis of data collected as part of Aim 2.
The group in the trial
- CT-MICART AppTreatment being tested
Participants in this arm will receive daily EMAs for 6 weeks.
Treatment: CT-MICART App and Control
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Mobile App to Address CUD Among Black Adults
- Publications
- Mobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial.JMIR research protocols, 2024
- Record updated
- 7 May 2024